Patent 11975162 was granted and assigned to STEMPLANT LLC on May, 2024 by the United States Patent and Trademark Office.
A method and apparatus for delivery of cell therapies, introduced via percutaneous access to the circulation, and delivered to the site of vascular injury intervention.